Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Feb;63(2):478–485. doi: 10.1128/iai.63.2.478-485.1995

Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.

J K Byron 1, K V Clemons 1, J H McCusker 1, R W Davis 1, D A Stevens 1
PMCID: PMC173020  PMID: 7822013

Abstract

We have previously determined the relative virulence of isolates of Saccharomyces cerevisiae on the basis of differences in proliferation and resistance to clearance in CD-1 mice. These infections were not fatal. To further characterize S. cerevisiae pathogenesis, we studied a virulent clinical isolate, YJM128, and an avirulent nonclinical isolate, Y55, in C5-deficient mice. DBA/2N mice were infected intravenously with YJM128 or Y55, and temporal burdens of yeast cells in various organs were determined. After infection with 10(7) CFU, Y55 increased by 13-fold and YJM128 increased by 20-fold in the brain from day 0 to 3. In addition, YJM128 increased by 4-fold in the kidneys, whereas Y55 decreased by 16-fold. Both isolates declined in number in other organs. In all studies, 90% of mice infected with 10(7) CFU of YJM128 died between days 2 and 7, whereas no mice infected with equivalent numbers of Y55 died. No mice died after infection with 10(6) CFU of Y55 or YJM128. The importance of C5 was confirmed by studies using B10.D2/oSnJ (C5-) mice and their congenic C5+ counterparts. Again, the C5- mice were most susceptible to infection with S. cerevisiae, with 63% infected with YJM128 dying by day 7; no C5+ mice died. No Y55-infected mice died, and mean burdens in the brain at day 14 were sevenfold lower in C5+ mice than in C5- mice. Seven of 10 other S. cerevisiae isolates were also more virulent in DBA/2N than CD-1 mice, causing > or = 40% mortality. These data indicate that C5 is a critical factor in host resistance against S. cerevisiae infections and further confirm the pathogenic potential of some isolates of S. cerevisiae.

Full Text

The Full Text of this article is available as a PDF (620.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aucott J. N., Fayen J., Grossnicklas H., Morrissey A., Lederman M. M., Salata R. A. Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis. 1990 May-Jun;12(3):406–411. doi: 10.1093/clinids/12.3.406. [DOI] [PubMed] [Google Scholar]
  2. Brummer E., Stevens D. A. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine. Cell Immunol. 1994 Aug;157(1):1–10. doi: 10.1006/cimm.1994.1200. [DOI] [PubMed] [Google Scholar]
  3. Burger E., Singer-Vermes L. M., Calich V. L. The role of C5 in experimental murine paracoccidioidomycosis. J Infect Dis. 1985 Aug;152(2):425–425. doi: 10.1093/infdis/152.2.425. [DOI] [PubMed] [Google Scholar]
  4. Calich V. L., Burger E., Kashino S. S., Fazioli R. A., Singer-Vermes L. M. Resistance to Paracoccidioides brasiliensis in mice is controlled by a single dominant autosomal gene. Infect Immun. 1987 Aug;55(8):1919–1923. doi: 10.1128/iai.55.8.1919-1923.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cimolai N., Gill M. J., Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis. 1987 Oct;8(2):113–117. doi: 10.1016/0732-8893(87)90158-1. [DOI] [PubMed] [Google Scholar]
  6. Clemons K. V., McCusker J. H., Davis R. W., Stevens D. A. Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis. 1994 Apr;169(4):859–867. doi: 10.1093/infdis/169.4.859. [DOI] [PubMed] [Google Scholar]
  7. Cox R. A., Kennell W., Boncyk L., Murphy J. W. Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect Immun. 1988 Jan;56(1):13–17. doi: 10.1128/iai.56.1.13-17.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doyle M. G., Pickering L. K., O'Brien N., Hoots K., Benson J. E. Saccharomyces cerevisiae infection in a patient with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1990 Nov;9(11):850–851. [PubMed] [Google Scholar]
  9. Eng R. H., Drehmel R., Smith S. M., Goldstein E. J. Saccharomyces cerevisiae infections in man. Sabouraudia. 1984;22(5):403–407. [PubMed] [Google Scholar]
  10. Eschete M. L., West B. C. Saccharomyces cerevisiae septicemia. Arch Intern Med. 1980 Nov;140(11):1539–1539. [PubMed] [Google Scholar]
  11. Gordon D. L., Hostetter M. K. Complement and host defence against microorganisms. Pathology. 1986 Oct;18(4):365–375. doi: 10.3109/00313028609087551. [DOI] [PubMed] [Google Scholar]
  12. Hector R. F., Domer J. E., Carrow E. W. Immune responses to Candida albicans in genetically distinct mice. Infect Immun. 1982 Dec;38(3):1020–1028. doi: 10.1128/iai.38.3.1020-1028.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hector R. F., Yee E., Collins M. S. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun. 1990 May;58(5):1476–1478. doi: 10.1128/iai.58.5.1476-1478.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Holzschu D. L., Chandler F. W., Ajello L., Ahearn D. G. Evaluation of industrial yeasts for pathogenicity. Sabouraudia. 1979 Mar;17(1):71–78. doi: 10.1080/00362177985380091. [DOI] [PubMed] [Google Scholar]
  15. Lyon F. L., Hector R. F., Domer J. E. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component. J Med Vet Mycol. 1986 Oct;24(5):359–367. doi: 10.1080/02681218680000551. [DOI] [PubMed] [Google Scholar]
  16. Maejima K., Shimoda K., Morita C., Fujiwara T., Kitamura T. Colonization and pathogenicity of Saccharomyces cerevisiae, MC16, in mice and cynomolgus monkeys after oral and intravenous administration. Jpn J Med Sci Biol. 1980 Oct;33(5):271–276. doi: 10.7883/yoken1952.33.271. [DOI] [PubMed] [Google Scholar]
  17. McCusker J. H., Clemons K. V., Stevens D. A., Davis R. W. Genetic characterization of pathogenic Saccharomyces cerevisiae isolates. Genetics. 1994 Apr;136(4):1261–1269. doi: 10.1093/genetics/136.4.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miller M. E., Nilsson U. R. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med. 1970 Feb 12;282(7):354–358. doi: 10.1056/NEJM197002122820702. [DOI] [PubMed] [Google Scholar]
  19. Miller M. E., Nilsson U. R. A major role of the fifth component of complement (C5) in the opsonization of yeast particles. Partial dichotomy of function and immunochemical measurement. Clin Immunol Immunopathol. 1974 Jan;2(2):246–255. doi: 10.1016/0090-1229(74)90042-7. [DOI] [PubMed] [Google Scholar]
  20. Morelli R., Rosenberg L. T. Role of complement during experimental Candida infection in mice. Infect Immun. 1971 Apr;3(4):521–523. doi: 10.1128/iai.3.4.521-523.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morelli R., Rosenberg L. T. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J Immunol. 1971 Aug;107(2):476–480. [PubMed] [Google Scholar]
  22. Nielsen H., Stenderup J., Bruun B. Fungemia with Saccharomycetaceae. Report of four cases and review of the literature. Scand J Infect Dis. 1990;22(5):581–584. doi: 10.3109/00365549009027100. [DOI] [PubMed] [Google Scholar]
  23. Oriol A., Ribera J. M., Arnal J., Milla F., Batlle M., Feliu E. Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol. 1993 Aug;43(4):325–326. doi: 10.1002/ajh.2830430424. [DOI] [PubMed] [Google Scholar]
  24. Rhodes J. C., Wicker L. S., Urba W. J. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun. 1980 Aug;29(2):494–499. doi: 10.1128/iai.29.2.494-499.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stratford M., Keenan M. H. Yeast flocculation: quantification. Yeast. 1988 Jun;4(2):107–115. doi: 10.1002/yea.320040204. [DOI] [PubMed] [Google Scholar]
  26. Tawfik O. W., Papasian C. J., Dixon A. Y., Potter L. M. Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome. J Clin Microbiol. 1989 Jul;27(7):1689–1691. doi: 10.1128/jcm.27.7.1689-1691.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wu-Hsieh B. Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum. Infect Immun. 1989 Dec;57(12):3788–3792. doi: 10.1128/iai.57.12.3788-3792.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES